Personal information

No personal information available

Activities

Collapse all

Employment (1)

Peking University Third Hospital: Beijing, CN

Prof. (Department of Obstetrics and Gynecology)
Employment
Source: Self-asserted source
Hongyan Guo

Education and qualifications (3)

Peking University: Beijing, CN

2001-09-01 to 2004-07-01 | Doctor
Education
Source: Self-asserted source
Hongyan Guo

Sichuan University: Chengdu, CN

1997-09-01 to 1999-07-01 | Master
Education
Source: Self-asserted source
Hongyan Guo

Peking University: Beijing, CN

1985-09-01 to 1991-07-01 | Bachelor
Education
Source: Self-asserted source
Hongyan Guo

Works (15)

Construction and validation of a prognostic model for overall survival time of patients with ovarian cancer by metabolism‐related genes

Journal of Obstetrics and Gynaecology Research
2024-08-04 | Journal article
DOI: 10.1111/jog.16044
Contributors: Deshui Kong; Hongyan Guo
Source: check_circle
Crossref

A prospective randomized multicenter trial for lymphadenectomy in early-stage ovarian cancer: LOVE study

Journal of Gynecologic Oncology
2023 | Journal article
DOI: 10.3802/jgo.2023.34.e52
Contributors: Ting Deng; Kaijiang Liu; Liang Chen; Xiaojun Chen; Hua Wen Li; Hongyan Guo; Huijiao Zhang; Libing Xiang; Xin Feng; Xiaoyu Wang et al.
Source: check_circle
Crossref

Profiling the metabolome of uterine fluid for early detection of ovarian cancer.

Cell reports. Medicine
2023-06-01 | Journal article
DOI: 10.1016/j.xcrm.2023.101061
PMID: 37267943
PMC: PMC10313936
Contributors: Wang P; Ma J; Li W; Wang Q; Xiao Y; Jiang Y; Gu X; Wu Y; Dong S; Guo H et al.
Source: Self-asserted source
Hongyan Guo

Associations of novel serum lipid index with epithelial ovarian cancer chemoresistance and prognosis.

Frontiers in oncology
2023-02-13 | Journal article
DOI: 10.3389/fonc.2023.1052760
PMID: 36860321
PMC: PMC9968862
Contributors: Li Y; Shang C; Liang H; Zhang K; Wu Y; Guo H
Source: Self-asserted source
Hongyan Guo

Heterogeneity of clinical symptoms and therapeutic strategies for different subtypes of adenomyosis: An initial single-center study in China.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
2023-01-24 | Journal article
DOI: 10.1002/ijgo.14650
PMID: 36605017
Contributors: Han X; Gao X; Wang F; Shang C; Liu Z; Guo H
Source: Self-asserted source
Hongyan Guo

Combined inhibition of PARP and EZH2 for cancer treatment: Current status, opportunities, and challenges.

Frontiers in pharmacology
2022-10-03 | Journal article
DOI: 10.3389/fphar.2022.965244
PMID: 36263120
PMC: PMC9574044
Contributors: Zhang X; Huo X; Guo H; Xue L
Source: Self-asserted source
Hongyan Guo

Microcystic, elongated and fragmented (MELF) pattern in endometrial carcinoma: clinicopathologic analysis and prognostic implications.

Medicine
2022-10-01 | Journal article
DOI: 10.1097/md.0000000000031369
PMID: 36316927
PMC: PMC9622715
Contributors: Song J; Jinghua Song; Guo H; Cai Y
Source: Self-asserted source
Hongyan Guo

Nanoalbumin-prodrug conjugates prepared via a thiolation-and-conjugation method improve cancer chemotherapy and immune checkpoint blockade therapy by promoting CD8<sup>+</sup> T-cell infiltration.

Bioengineering & translational medicine
2022-07-30 | Journal article
DOI: 10.1002/btm2.10377
PMID: 36684090
PMC: PMC9842047
Contributors: Long Chen; Xu N; Wang P; Zhu H; Zhang Z; Yang Z; Zhang W; Guo H; Jian Lin
Source: Self-asserted source
Hongyan Guo

Ascitic Senescent T Cells Are Linked to Chemoresistance in Patients With Advanced High-Grade Serous Ovarian Cancer.

Frontiers in oncology
2022-07-07 | Journal article
DOI: 10.3389/fonc.2022.864021
PMID: 35875098
PMC: PMC9301961
Contributors: Zhang J; He T; Yin Z; Shang C; Xue L; Guo H
Source: Self-asserted source
Hongyan Guo

Robust prognostic model based on immune infiltration-related genes and clinical information in ovarian cancer.

Journal of cellular and molecular medicine
2022-06-23 | Journal article
DOI: 10.1111/jcmm.17360
PMID: 35735060
PMC: PMC9258710
Contributors: Zhang X; Weikaixin Kong; Gao M; Huang W; Peng C; Huang Z; Xie Z; Guo H
Source: Self-asserted source
Hongyan Guo

Establish of an Initial Platinum-Resistance Predictor in High-Grade Serous Ovarian Cancer Patients Regardless of Homologous Recombination Deficiency Status.

Frontiers in oncology
2022-03-18 | Journal article
DOI: 10.3389/fonc.2022.847085
PMID: 35372049
PMC: PMC8971787
Contributors: Li Y; Nie Y; Guo H; Guo H; Ha C; Li Y
Source: Self-asserted source
Hongyan Guo

MAP4K4 mediates the SOX6-induced autophagy and reduces the chemosensitivity of cervical cancer

Cell Death & Disease
2021-12-20 | Journal article
DOI: 10.1038/s41419-021-04474-1
Contributors: Hongxin Huang; Qin Han; Han Zheng; Mingchen Liu; Shu Shi; Ting Zhang; Xingwen Yang; Zhongqing Li; Qiang Xu; Hongyan Guo et al.
Source: check_circle
Crossref

The prognostic miR-532-5p-correlated ceRNA-mediated lipid droplet accumulation drives nodal metastasis of cervical cancer.

Journal of advanced research
2021-09-22 | Journal article
DOI: 10.1016/j.jare.2021.09.009
PMID: 35499057
PMC: PMC9040090
Contributors: Shang C; Li Y; He T; Liao Y; Du Q; Wang P; Qiao J; Guo H
Source: Self-asserted source
Hongyan Guo

Identification of an Metabolic Related Risk Signature Predicts Prognosis in Cervical Cancer and Correlates With Immune Infiltration.

Frontiers in cell and developmental biology
2021-06-24 | Journal article
DOI: 10.3389/fcell.2021.677831
PMID: 34249930
PMC: PMC8264424
Contributors: Shang C; Huang J; Guo H
Source: Self-asserted source
Hongyan Guo

Senescent T cells: a potential biomarker and target for cancer therapy.

EBioMedicine
2021-05-25 | Journal article
DOI: 10.1016/j.ebiom.2021.103409
PMID: 34049248
PMC: PMC8170103
Contributors: Jie Zhang; He T; Xue L; Guo H
Source: Self-asserted source
Hongyan Guo
How many people are using ORCID?